The use of immunohistochemistry for biomarker assessment-Can it compete with other technologies?

Toxicologic Pathology

Volumn 39, Issue 6, 2011, Pages 988-1002

  Dunstan, Robert W ^a   Wharton Jr , Keith A ^a   Quigley, Catherine ^a   Lowe, Amanda ^b  

^a BIOGEN   (United States)

^b Digital Pathology Consultants   (United States)

Author keywords

image analysis; immunohistochemistry; standardization; whole slide imaging

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; NUCLEIC ACID; PROGESTERONE RECEPTOR; PROTEIN;

ACCURACY; ARTICLE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HISTOLOGY; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MICROSCOPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAINING; TISSUE FIXATION; TISSUE SECTION;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 80053599098     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311419163     Document Type: Article

References (93)

1. Alymani N. A., Smith M. D., Williams D. J., Petty R. D.. Predictive biomarkers for personalised anti-cancer drug use: Discovery to clinical implementation. Eur J Cancer. 2010 ; 46: 869-79
2. Apple S., Pucci R., Lowe A.C., Shintaku I., Shapourifar-Tehrani S., Moatamed N.. The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma. Am J Clin Pathol. 2011 ; 135: 592-8
3. Atkins D., Reiffen K. A., Tegtmeier C. L., Winther H., Bonato M. S., Störkel S.. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: Variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem. 2004 ; 7: 893-901 (Pubitemid 38857154)
4. Babic A., Loftin I. R., Stanislaw S., Wang M., Miller R., Warren S. M., Zhang W., Lau A., Miller M., Wu P., Padilla M., Grogan T. M., Pestic-Dragovich L., McElhinny A. S.. The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in-situ hybridization and fluorescent in situ hybridization assays. Methods. 2010 ; 52: 287-300
5. Bernardo V., Lourenço S. Q., Cruz R., Monteiro-Leal L. H., Silva L. E., Camisasca D. R., Farina M., Lins U.. Reproducibility of immunostaining quantification and description of a new digital image processing procedure for quantitative evaluation of immunohistochemistry in pathology. Microsc Microanal. 2009 ; 15: 353-65
6. Best S., Sawyers Y., Fu V. X.. Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy. Urology. 2007 ; 70: 328-32 (Pubitemid 47362264)
7. Biomarkers and surrogate endpoints: Preferred and conceptual framework. Clin Pharmacol Ther. 2001 ; 69: 89-95
8. Boyce R. W., Dorph-Petersen K. A., Lyck L., Gundersen H. J.. Design-based stereology: Introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol. 2010 ; 38: 1011-25
9. Burns J. A., Li Y., Cheney C. A., Ou Y., Franlin-Pfeifer L. L., Kuklin N., Zhang Z. Q.. Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues. J Histochem Cytochem. 2009 ; 57: 257-64
10. Carlson G. D., Calvanese C. B., Kahane H., Epstein J. I.. Accuracy of biopsy Gleason scores from a large uropathology laboratory: Use of a diagnostic protocol to minimize observer variability. Urology. 1998 ; 51: 525-9 (Pubitemid 28186200)
11. Castleman K. R. Microscope Image Processing. Wu Q. Merchant F. A. Castleman K. R., ed. Burlington, MA: Academic Press ; 2008: 27-38.
12. Chen G., Gharib T. G., Huang C. C., Taylor J. M., Misek D. E., Kardia S. L., Giordano T. J., Iannettoni M. D., Orringer M. B., Hanash S. M., Beer D. G.. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002 ; 4: 304-13
13. Chung J.-Y., Hewitt S. M. Methods in Molecular Biology, Protein Blotting and Detection. Kurien B. T. Scofield R. H., ed. Totowa, NJ: Humana Press ; 2009: 139-48.
14. Coco D. P., Goldblum J. R., Hornick J. L., Lauwers G. Y., Montgomery E., Srivastava A., Wang H., Odze R. D.. Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus. Am J Surg Pathol. 2011 ; 35: 45-54
15. Compton C. C.. The surgical specimen is the personalized part of personalized cancer medicine. Ann Surg Oncol. 2009 ; 16: 2079-80
16. Copete M., Garratt J., Gilks B., Pilavdzic D., Berendt R., Bigras G., Mitchell S., Lining L. A., Cheung C., Torlakovic E. E.. Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experience. J Clin Pathol. 2011 ; 64: 220-5
17. Cox M. L., Eddy S. M., Stewart Z. S., Kennel M. R., Man M. Z., Paulauskis J. D., Dunstan R. W.. Investigating fixative-induced changes in RNA quality and utility by microarray analysis. Exp Mol Pathol. 2008 ; 84: 156-72
18. Cummings J., Raynaud F., Jones L., Sugar R., Dive C.. Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br J Cancer. 2010 ; 103: 1313-7
19. Cummings J., Ward T. H., Dive C.. Fit-for-purpose biomarker validation for anticancer drug development. Drug Disc Today. 2010 ; 15: 816-25
20. Cummings J., Ward T.H., Greystoke A., Ransom M., Dive C.. Biomarker method validation in anticancer drug development. Br J Pharmacol. 2008 ; 153: 646-56 (Pubitemid 351271750)
21. Dalton L. W., Page D. L., Dupont W. D.. Histologic grading of breast carcinoma. A reproducibility study. Cancer. 1994 ; 73: 2765-70 (Pubitemid 24166264)
22. Dapson R. W.. Macromolecular changes caused by formalin fixation and antigen retrieval. Biotech Histochem. 2007 ; 82: 133-40 (Pubitemid 350090067)
23. Diamandis E. P.. Cancer biomarkers: Can we turn recent failures into success?. J Natl Cancer Inst. 2010 ; 102: 1462-7
24. DoorenJ. C. (2010). Drug approvals slipped in 2010. The Wall Street Journal On Line. http://online.wsj.com/article/ SB10001424052748704543004576052170335871018.html
25. Engers R.. Reproducibility and reliability of tumor grading in urological neoplasms. World J. 2007 ; 25: 595-605
26. Evered A., Dudding N.. Accuracy and perceptions of virtual microscopy compared with glass slide microscopy in cervical cytology. Cytopathology. 2010 ; 10: 111-5
27. Fandel T. M., Pfnür M., Schäfer S. C., Bacchetti P., Mast F. W., Corinth C., Ansorge M., Melchior S. W., Thüroff J. W., Kirkpatrick C. J., Lehr H. A.. Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol. 2008 ; 216: 193-200
28. Farmer E. R., Gonin R., Hanna M. P.. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol. 1996 ; 27: 528-31 (Pubitemid 26187274)
29. Food and Drug Administration Center for Devices and Radiological Health, Medical Devices Advisory Committee (2010). Meeting Transcript(October 23, 2009: Hematology and Pathology Devices Panel Meeting).
30. Foucar E.. When and to what end do pathologists agree?. J Natl Cancer Inst. 1998 ; 90: 1014-6
31. Foucar E.. Diagnostic precision and accuracy in interpretation of specimens from cancer screening programs. Semin Diagn Pathol. 2005 ; 22: 147-55
32. Fox C. H., Johnson F. B., Whiting J., Roller P. P.. Formaldehyde fixation. J Histochem Cytochem. 1985 ; 33: 845-53
33. Goldstein N. S., Ferkowicz M., Odish E., Mani A., Hastah F.. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003 ; 120: 86-92 (Pubitemid 37046374)
34. Grizzle W. E.. Special symposium: fixation and tissue processing models. Biotech Histochem. 2009 ; 84: 185-93
35. Grunkin M., Raundahl J., Foged N. T.. Practical considerations of image analysis and quantification of signal transduction IHC staining. Signal Transduction Immunohistochemistry: Methods and Protocols, Methods in Molecular Biology. 2011 ; Vol. 717: 143-54
36. Hamilton P. W., van Diest P. J., Williams R., Gallagher A. G.. Do we see what we think we see? The complexities of morphological assessment. J Pathol. 2010 ; 218: 285-91
37. Hammond M. E., Hayes D. F., Dowsett M., Allred D. C., Hagerty K. L., Badve S., Fitzgibbons P. L., Francis G., Goldstein N. S., Hayes M., Hicks D. G., Lester S., Love R., Mangu P. B., McShane L., Miller K., Osborne C. K., Paik S., Perlmutter J., Rhodes A., Sasano H., Schwartz J. N., Sweep F. C., Taube S., Torlakovic E. E., Valenstein P., Viale G., Visscher D., Wheeler T., Williams R. B., Wittliff J. L., Wolff A. C.. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med. 2010 ; 134: 907-22
38. Hedvat C. V.. Digital microscopy: Past, present, and future. Arch Pathol Lab. 2010 ; 134: 1666-70
39. Howard C. V., Reed M. G. Unbiased Stereology. 2005 ). Random sampling and random geometry. In Unbiased Stereology (HowardC. V.ReedM.G., eds.), 2nd Edition, pp. 17-33. BIOS Scientific Publishers, New York, NY. Howard C. V. Reed M.G., ed. New York, NY: BIOS Scientific Publishers ; 2005: 17-33.
40. Hsia C. C., Hyde D. M., Ochs M., Weibel E. R.. An official research policy statement of the American Thoracic Society/European Respiratory Society: Standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010 ; 181: 394-18
41. Ibarra J. A., Rogers L. W., Kyshtoobayeva A., Bloom K.. Fixation time does not affect the expression of estrogen receptor. Am J Clin Pathol. 2010 ; 133: 747-55
42. Khleif S. N., Doroshow J. H., Hait W. N.. AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: Advancing the use of biomarkers in cancer drug development. Clin Cancer Res. 2010 ; 16: 3299-318
43. Koch L. H., Lampros J. N., Delong L. K., Chen S. C., Woosley J. T., Hood A. F.. Randomized comparison of virtual microscopy and traditional glass microscopy in diagnostic accuracy among dermatology and pathology residents. Hum Pathol. 2009 ; 40: 662-7
44. Komaki K., Sano N., Tangoku A.. Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast Cancer. 2006 ; 13: 249-53
45. Landis J. R., Koch G. G.. The measurement of observer agreement for categorical data. Biometrics. 1977 ; 33: 159-74 (Pubitemid 8054849)
46. Lee J. W.. Method validation and application of protein biomarkers: Basic similarities and differences from biotherapeutics. Bioanalysis. 2009 ; 1: 1461-74
47. Lee J. W., Devanarayan V., Barrett Y. C., Weiner R., Allinson J., Fountain S., Keller S., Weinryb I., Green M., Duan L., Rogers J. A., Millham R., O'Brien P. J., Sailstad J., Khan M., Ray C., Wagner J. A.. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res. 2006 ; 23: 312-28 (Pubitemid 43237862)
48. Leong A. S.. Quantitative immunohistology: Tissue section thickness, another glitch in the path to standardization. Appl Immunohistochem Mol Morphol. 2009 ; 17: 465-9
49. Leong A. S., Leong T. Y.. Standardization in immunohistology. Methods Mol Biol. 2011 ; 724: 37-68
50. Leong T. Y., Cooper K., Leong A. S.. Immunohistology-past, present, and future. Adv Anat Pathol. 2010 ; 17: 404-18
51. Letourneux H., Lindner V., Lang H., Massfelder T., Meyer N., Saussine C., Jacqmin D.. Reproducibility of Fuhrman nuclear grade: Advantages of a two-grade system. Prog Urol. 2006 ; 16: 281-5 (Pubitemid 44911967)
52. LittleE. (2010). What difference does a difference make? Visions Conference. http://digitalpathologyassociation.org/-data/files/2010- Presentations/Little-What-Difference-Does-A-Difference-Make.ppt
53. Lloyd M. C., Allam-Nandyala P., Purohit C. N., Burke N., Coppola D., Bui M. M.. Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it?. J Pathol Inform. 2011 ; 1: 29
54. Longacre T. A., Ennis M., Quenneville L. A., Bane A. L., Bleiweiss I. J., Carter B. A., Catelano E., Hendrickson M. R., Hibshoosh H., Layfield L. J., Memeo L., Wu H., O'Malley F. P.. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: An NCI breast cancer family registry study. Mod Pathol. 2006 ; 19: 195-207 (Pubitemid 43117604)
55. Mackenzie S., Ware C. Lag as a Determinant of Human Performance in Interactive Systems. 1993: 488-93.
56. Majewski I. J., Bernards R.. Taming the dragon: Genomic biomarkers to individualize the treatment of cancer. Nat Med. 2011 ; 17: 304-12
57. Mardis E. R.. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008 ; 24: 133-41
58. Mass R. Biomarkers of Breast Cancer. Gasparini G. Hayes D. F., ed. Towtowa, NJ: Humana Press ; 2006: 159-73.
59. McCabe A., Dolled-Filhart M., Camp R. L., Rimm D. L.. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst. 2005 ; 97: 1808-15 (Pubitemid 43033901)
60. McCluggage W. G., Hirschowitz L., Wilson G. E., Oliva E., Soslow R. A., Zaino R. J.. Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study. Am J Surg Pathol. 2011 ; 35: 289-94
61. Mengel M., von Wasielewski R., Wiese B., Rüdiger T., Müller-Hermelink H. K., Kreipe H.. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol. 2002 ; 198: 292-9 (Pubitemid 35277379)
62. MillerR. T. (2010). What every pathologist needs to know about technical immunohistochemistry (or how to avoid "immunoconfusion"). Presentation to American Academyof Oral and Maxillofacialy Pathology. http://www.aaomp.org/ annual-meeting/2010-CE5-Miller-Tech-minicourse.pdf.
63. Molyneux G., Smalley M. J.. The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling. J Mammary Gland Biol Neoplasia. 2011 ; 16: 51-9
64. Montgomery E.. Is there a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia?. Arch Pathol Lab Med. 2005 ; 129: 174-6 (Pubitemid 40204791)
65. Mooney E., Hood A. F., Lampros J., Kempf W., Jemec G. B.. Comparative diagnostic accuracy in virtual dermatopathology. Skin Res Technol. 2011 ; 17: 251-5
66. Navin N. E., Hicks J.. Tracing the tumor lineage. Mol Oncol. 2010 ; 4: 267-83
67. Oyama T., Ishikawa Y., Hayashi M., Arihiro K., Horiguchi J.. The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer. 2007 ; 14: 182-8
68. Puchtler H., Meloan S. N.. On the chemistry of formaldehyde fixation and its effects on immunohistochemical reactions. Histochemistry. 1985 ; 82: 201-4 (Pubitemid 15114056)
69. Raji A.. Human epidermal growth factor receptor 2 testing recommendation (Author reply). J Clin Oncol. 2007 ; 25: 4020-1 (Pubitemid 47477286)
70. Ramos-Vara J. A.. Principles and methods of immunohistochemistry. Methods Mol Biol. 2011 ; 691: 83-96
71. Rojo M. G., Bueno G., Slodkowska J.. Review of imaging solutions for integrated quantitative immunohistochemistry in the pathology daily practice. Folia Histochem Cytobiol. 2009 ; 47: 349-54
72. Rojo M. G., García G. B., Mateos C. P., García J. G., Vicente M. C.. Critical comparison of 31 commercially available digital slide systems in pathology. Int J Surg Pathol. 2006 ; 14: 285-305 (Pubitemid 44545765)
73. Rugge M., Correa P., Dixon M. F., Fiocca R., Hattori T., Lechago J., Leandro G., Price A. B., Sipponen P., Solcia E., Watanabe H., Genta R. M.. Gastric mucosal atrophy: Interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002 ; 16: 1249-59
74. Samaratunga H., Montironi R., True L., Epstein J. I., Griffiths D. F.. International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical-prostatectomy specimens. Working group 1: specimen handling. Mod Pathol. 2011 ; 24: 5-15
75. Schlomm T., Näkel E., Lübke A., Buness A., Chun F. K., Steuber T., Graefen M., Simon R., Sauter G., Poustka A., Huland H., Erbersdobler A., Sültmann H., Hellwinkel O. J.. Marked gene transcript level alterations occur during early radical prostatectomy. Eur Urol. 2008 ; 53: 33-46
76. Seel M., Gerdes M., Gerald W., Sood A., Barnhardt N., Ginty F., Montalto M. C.. Novel fluorescence immunohistochemistry multiplexing technique for imaging multiple breast cancer biomarkers. FASEB Journal. 2007 ; 21: lb319
77. Sheehan D. C., Hrapchak B. B. Theory and Practice of Histotechnology. Sheehan D. C. Hrapchak B. B., ed. Columbus, OH: Battelle Press ; 1987: ix.
78. Shi S. R., Liu C., Taylor C. R.. Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: From experiments to hypothesis. Histochem Cytochem. 2007 ; 55: 105-9 (Pubitemid 46147687)
79. Sloane J. P., Amendoeira I., Apostolikas N., Bellocq J. P., Bianchi S., Boecker W., Bussolati G., Coleman D., Connolly C. E., Eusebi V., De Miguel C., Dervan P., Drijkoningen R., Elston C. W., Faverly D., Gad A., Jacquemier J., Lacerda M., Martinez-Penuela J., Munt C., Peterse J. L., Rank F., Sylvan M., Tsakraklides V., Zafrani B.. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch. 1999 ; 434: 3-10 (Pubitemid 29184895)
80. Saodkowska J., Markiewicz T., Grala B., Wojciech K., Papierz W., Pleskacz K., Murawski P.. Accuracy of a remote quantitative image analysis in the whole slide images. Diag Pathol. 2011 ; 6 ((Suppl. 1)). S20
81. Spruessel A., Steimann G., Jung M., Lee S. A., Carr T., Fentz A. K., Spangenberg J., Zornig C., Juhl H. H., David K. A.. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. Biotechniques. 2004 ; 36: 1030-7 (Pubitemid 38747367)
82. Straus S. E., Sackett D. L.. Applying evidence to the individual patient. Ann Oncol. 1999 ; 10: 29-32 (Pubitemid 29090588)
83. Taylor C. R.. The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med. 2000 ; 124: 945-51 (Pubitemid 30602035)
84. Taylor C. R. 2009 ). Immunohistochemical standardization and ready-to-use antibodies. Chapter 4 in Immunohistochemical Staining Methods, 5th Edition. Dako North America, Carpenteria, CA. Carpenteria, CA: Dako North America ; 2009 :
85. Taylor C. R., Levenson R. M.. Quantification of immunohistochemistry- issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006 ; 49: 411-24 (Pubitemid 44401549)
86. True L. D.. Quality control in molecular immunohistochemistry. Histochem Cell Biol. 2008 ; 130: 473-80
87. Tsuda H., Akiyama F., Kurosumi M., Sakamoto G., Yamashiro K., Oyama T., Hasebe T., Kameyama K., Hasegawa T., Umemura S., Honma K., Ozawa T., Sasaki K., Morino H., Ohsumi S.. Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol. Jpn J Cancer Res. 2000 ; 91: 451-7 (Pubitemid 30312699)
88. van den Bent M. J.. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective. Acta Neuropathol. 2010 ; 120: 297-304
89. Walk E. E.. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare. Curr Opin Drug Discov Devel. 2010 ; 13: 226-34
90. Webster J. D., Miller M. A., Dusold D., Ramos-Vara J.. Effects of prolonged formalin fixation on diagnostic immunohistochemistry in domestic animals. J Histochem Cytochem. 2009 ; 57: 753-61
91. Wolff A. C., Hammond M. E., Schwartz J. N., Hagerty K. L., Allred D. C., Cote R. J., Dowsett M., Fitzgibbons P. L., Hanna W. M., Langer A., McShane L. M., Paik S., Pegram M. D., Perez E. A., Press M. F., Rhodes A., Sturgeon C., Taube S. E., Tubbs R., Vance G. H., van de Vijver M., Wheeler T. M., Hayes D. F.. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007 ; 131: 18-43 (Pubitemid 46174133)
92. Xie R., Chung J.Y., Ylaya K., Williams R.L., Guerrero N., Nakatsuka N., Badie C., Hewitt S.M.. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem. 2011 ; 59: 356-65
93. Ying X., Monticello T. M.. Modern imaging technologies in toxicologic pathology: An overview. Toxicol Pathol. 2006 ; 34: 815-26 (Pubitemid 46011137)